Home » Digital Therapeutics Market

Digital Therapeutics Market By Product Type (Software, Devices), By Application (Diabetes, Obesity, Cardiovascular Diseases, CNS Diseases, Respiratory Diseases, Smoking Cessation) – Growth, Future Prospects, And Competitive Analysis, 2017 -2025

Price: $4999

Published: | Report ID: 5029 | Report Format : PDF

Digital therapeutics is a platform that utilizes digital tools, such as software or devices, to monitor treatment regimens and also treat medical conditions. This platform builds a bridge between patients, payers, and physicians, thus helping in the monitoring of treatment, ensuring adherence to medications, and also curbing healthcare costs. Owing to an increase in the adoption and utilization of the internet, smartphones, and tablets, an increase in demand for reduced healthcare costs, and a rising focus on preventive healthcare, the digital therapeutics market is projected to expand during the forecast period of 2017–2025.

The current report compilation on the digital therapeutics market encompasses an elaborate market outlook and dynamics, along with a thorough analysis of the current and upcoming future market scenarios. In-depth market evaluation in terms of US$ Mn, forecast analysis with annual growth rates, and market evolution during the period 2017–2025 are some of the key inclusions of this report.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample
CTA Design Element 3

The digital therapeutics market is segmented based on the availability of various kinds of products in the market, the vivid applications of digital therapeutics, and the outreach of digital therapeutics amongst geographies. Hence, the various market segments incorporated in this report include product type, application, and geography. The product type is segmented as “software” and “devices.” Devices are sub-segmented as pain management devices, rehabilitation devices, respiratory therapy devices, and glucose monitoring devices. The application segment comprises diabetes, obesity, cardiovascular diseases, CNS diseases, respiratory diseases, smoking cessation, and other chronic conditions.

North America (Canada and the United States of America), Europe (Germany, the United Kingdom, and the Rest of Europe), Asia Pacific (India, Japan, and the Rest of Asia Pacific), Latin America (Mexico, Brazil, and the Rest of Latin America), and the Middle East and Africa (the GCC and the Rest of the Middle East and Africa) are among the geographies studied in this report. The aforementioned segments are studied in depth, and market estimations and forecast analyses are performed for each of the segments. Each segment’s market share in US dollars million has been included, as have their respective growth rates.

The report also encompasses qualitative factors such as market drivers, restraints, and opportunities that would help gauge a better understanding of the market dynamics and market trends of digital therapeutics. The digital therapeutics market is comprised of a large competitive pool. Constant partnerships, device withdrawals, and advanced device additions in the market are a few market trends that change the market’s outlook. This report provides an in-depth explanation of market attractiveness analysis, the competitive landscape, partnerships and collaborations, and upcoming advancements during the forecast period. Additionally, the report also comprises profiles of dominant players holding strong positions in the digital therapeutics market. The dominant players profiled in the current report are Omada Health, Inc., Evolent Health, Inc., Perfint Healthcare Pvt. Ltd., Nanobiosym, Inc., Zest Health, Doximity, Inc., Pear Therapeutics, Inc., Evolent Health, Inc., WellDoc, Inc., 2Morrow, Inc., Proteus Digital Health, Livongo Health, Twinehealth, Inc., Propeller Health, Mango Health, Inc., Inc., Canary Health.

Based on product types, the global digital therapeutics market is segmented as follows:

  • Software
  • Devices
  • Pain management devices
  • Rehabilitation devices
  • Respiratory therapy devices
  • Glucose monitoring devices

Digital therapeutic products are either software or devices. Software and devices provide the required lifestyle modification guidance and treatment monitoring features. The software segment dominates the digital therapeutics market owing to ease of availability, reduced cost in comparison to devices, accessibility on smartphones, and a patient-friendly interface. Software stores the daily monitored data in a cloud-based system, which can be retrieved as and when required. This integrated system creates a bridge between caregivers and patients, thus ensuring timely patient care. Software or devices help implement treatment programs specific to major chronic diseases like diabetes, heart disease, high blood pressure, and pulmonary diseases like COPD. These solutions help to limit and prevent the severity of life-threatening conditions through lifestyle and behavioral changes. The devices segment is expected to show moderate growth during the forecast period, owing to the lack of awareness and availability of such digital therapeutic devices in developing economies. However, rising physician prescriptions would show a significant increase in the digital therapeutics market.

Based on applications, the global digital therapeutics market is segmented as follows:

  • Diabetes
  • Obesity
  • Cardiovascular Diseases
  • CNS Diseases
  • Respiratory Diseases
  • Smoking Cessation
  • Others

Digital therapeutics are predominantly accepted and utilized for chronic disease management. The most common types of chronic diseases mentioned in the study include diabetes, obesity, cardiovascular diseases, CNS diseases, respiratory diseases, and others. Diabetes held the largest market share when compared to other areas in the digital therapeutics market. The diabetes segment holds the highest potential in the digital therapeutics market as it is a lifestyle-related disorder, and the prevalence of diabetes is on the rise globally. According to the International Diabetes Federation (IDF), 415 million individuals had diabetes in 2015, which is projected to reach 642 million by 2040.

Digital therapeutic techniques help in monitoring insulin or oral anti-hyperglycemic treatment on a regular basis, resulting in patient adherence. Obesity held the second-largest market by application for digital therapeutics, owing to the growing number of obesity cases and rising awareness regarding fitness among the masses. As per the World Health Organization (WHO), obesity accounted for 13% of the world’s population in 2016. Digital therapeutic techniques help with fitness management and weight reduction by monitoring daily lifestyle patterns, providing periodic reminders for exercise, and monitoring calories.

For the purpose of this study, the digital therapeutics market is categorized into three segments:

  • North America
  • Europe
  • Asia Pacific
  • Latin America (LATAM)
  • Middle East and Africa (MEA)

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Among the aforementioned regions, North America accounts for a major share of the digital therapeutic market. The factors driving this market are a developed healthcare infrastructure with improved reimbursement policies, a push toward a patient-centric healthcare approach, and technological advancements in healthcare monitoring. The increasing number of digital therapy providers in North America also accounts for the growth in this market region. The market for Asia Pacific is anticipated to rise at an increased rate during the forecast period of 2017–2025. The rise in growth of the Asia Pacific market can be attributed to market drivers such as the rising chronic disease population and the increasing availability and acceptance of the latest healthcare technologies. This market is also driven by the continuous development of healthcare infrastructure and efforts to maintain sustainable healthcare growth through financial inclusion.

Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global Digital Therapeutics Market Portraiture
2.1.1. Global Digital Therapeutics Market, by Product Type, 2016 (US$ Mn)
2.1.2. Global Digital Therapeutics Market, by Application, 2016 (US$ Mn)
2.1.3. Global Digital Therapeutics Market, by Geography, 2016 vs. 2025 (US$ Mn)

Chapter 3. Global Digital Therapeutics Market: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Digital Therapeutics: Future Trends
3.3. Drivers
3.4. Challenges
3.5. Opportunities
3.6. Attractive Investment Proposition, by Geography, 2016
3.7. Major Agreements, Partnerships and Collaborations
3.8. Competitive Landscape, by Key Players, 2016

Chapter 4. Global Digital Therapeutics Market, by Product Type, 2015 – 2025 (US$ Mn)
4.1. Overview
4.1.1. Attractive Investment Proposition: Global Digital Therapeutics Market, by Product Type , 2016
4.2. Software
4.3. Devices
4.3.1. Pain management Devices
4.3.2. Rehabilitation Devices
4.3.3. Respiratory Therapy Devices
4.3.4. Glucose Monitoring Devices

Chapter 5. Global Digital Therapeutics Market, by Application , 2015 – 2025 (US$ Mn)
5.1. Overview
5.1.1. Attractive Investment Proposition: Global Digital Therapeutics Market, byApplication Type, 2016
5.2. Diabetes
5.3. Obesity
5.4. Cardiovascular Diseases
5.5. CNS Diseases
5.6. Respiratory Diseases
5.7. Smoking Cessation
5.8. Others

Chapter 6. Global Digital Therapeutics Market, by Geography, 2015 – 2025 (US$ Mn)
6.1. Overview
6.2. North America Digital Therapeutics Market Analysis, 2015 – 2025
6.2.1. North America Digital Therapeutics Market, by Product Type, 2015 – 2025(US$ Mn)
6.2.2. North America Digital Therapeutics Market, by Application , 2015 – 2025(US$ Mn)
6.2.3. North America Digital Therapeutics Market, by Country, 2015 – 2025 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe Digital Therapeutics Market Analysis, 2015 – 2025
6.3.1. Europe Digital Therapeutics Market, by Product Type, 2015 – 2025(US$ Mn)
6.3.2. Europe Digital Therapeutics Market, by Application, 2015 – 2025(US$ Mn)
6.3.3. Europe Digital Therapeutics Market, by Country, 2015 – 2025 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific Digital Therapeutics Market Analysis, 2015 – 2025
6.4.1. Asia Pacific Digital Therapeutics Market, by Product Type, 2015 – 2025(US$ Mn)
6.4.2. Asia Pacific Digital Therapeutics Market, by Application, 2015 – 2025(US$ Mn)
6.4.3. Asia Pacific Digital Therapeutics Market, by Country, 2015 – 2025 (US$ Mn)
6.4.3.1. Japan
6.4.3.2. China
6.4.3.3. Rest of APAC
6.5. Latin America Digital Therapeutics Market Analysis, 2015 – 2025
6.5.1. Latin America Digital Therapeutics Market, by Product Type, 2015 – 2025(US$ Mn)
6.5.2. Latin America Digital Therapeutics Market, by Application, 2015 – 2025(US$ Mn)
6.5.3. Latin America Digital Therapeutics Market, by Country, 2015 – 2025(US$ Mn)
6.5.3.1. Mexico
6.5.3.2. Brazil
6.5.3.3. Rest of Latin America
6.6. Middle East & Africa (MEA) Digital Therapeutics Market Analysis, 2015 – 2025
6.6.1. MEA Digital Therapeutics Market, by Product Type, 2015 – 2025(US$ Mn)
6.6.2. MEA Digital Therapeutics Market, by Application, 2015 – 2025(US$ Mn)
6.6.3. MEA Digital Therapeutics Market, by Country, 2015 – 2025(US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA

Chapter 7. Company Profiles
7.1. 2Morrow, Inc.
7.1.1. Business Description
7.1.2. Financial Information(Subject to data availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. Canary Health, Inc.
7.3. Doximity, Inc.
7.4. Evolent Health, Inc.
7.5. Livongo Health
7.6. Mango Health, Inc.
7.7. Nanobiosym, Inc.
7.8. Noom Health, Inc.
7.9. Omada Health, Inc.
7.10. Pear Therapeutics, Inc.
7.11. Perfint Healthcare Pvt. Ltd.
7.12. Propeller Health
7.13. Proteus Digital Health
7.14. Twinehealth, Inc.
7.15. WellDoc Inc.
7.16. Zest Health

List of Figures

FIG. 1 Digital Therapeutics: Market Segmentation
FIG. 2 Attractive Investment Proposition, by Geography, 2016
FIG. 3 Market Competition Landscape, by Key Players, 2016
FIG. 4 Global Software Market In Digital Therapeutics, 2015 – 2025 (US$ Mn)
FIG. 5 Global Pain Management Devices Market in Digital Therapeutics, 2015 – 2025 (US$ Mn)
FIG. 6 Global Rehabilitation Devices Market in Digital Therapeutics, 2015 – 2025 (US$ Mn)
FIG. 7 Global Respiratory Therapy Devices Market in Digital Therapeutics, 2015 – 2025 (US$ Mn)
FIG. 8 Global Glucose Monitoring Devices Market in Digital Therapeutics, 2015 – 2025 (US$ Mn)
FIG. 9 Global Diabetes Market in Digital Therapeutics, 2015 – 2025 (US$ Mn)
FIG. 10 Global Obesity Market in Digital Therapeutics, 2015 – 2025 (US$ Mn)
FIG. 11 Global Cardiovascular Diseases Market in Digital Therapeutics, 2015 – 2025 (US$ Mn)
FIG. 12 Global CNS Diseases Market in Digital Therapeutics, 2015 – 2025 (US$ Mn)
FIG. 13 Global Respiratory Diseases Market in Digital Therapeutics, 2015 – 2025 (US$ Mn)
FIG. 14 Global Smoking Cessation Market in Digital Therapeutics, 2015 – 2025 (US$ Mn)
FIG. 15 Global Other Application Market in Digital Therapeutics, 2015 – 2025 (US$ Mn)
FIG. 16 U.S. Digital Therapeutics Market, 2015 – 2025 (US$ Mn)
FIG. 17 Canada Digital Therapeutics Market, 2015 – 2025 (US$ Mn)
FIG. 18 U.K. Digital Therapeutics Market, 2015 – 2025 (US$ Mn)
FIG. 19 Germany Digital Therapeutics Market, 2015 – 2025 (US$ Mn)
FIG. 20 Rest Of Europe Digital Therapeutics Market, 2015 – 2025 (US$ Mn)
FIG. 21 Japan Digital Therapeutics Market, 2015 – 2025 (US$ Mn)
FIG. 22 China Digital Therapeutics Market, 2015 – 2025 (US$ Mn)
FIG. 23 Rest Of Asia Pacific Digital Therapeutics Market, 2015 – 2025 (US$ Mn)
FIG. 24 Mexico Digital Therapeutic Market 2015-2025 (US$ Mn)
FIG. 25 Brazil Digital Therapeutics Market 2015-2025 (US$ Mn)
FIG. 26 Rest of Latin America Digital Therapeutics Market 2015-2025 (US$ Mn)
FIG. 27 GCC Digital Therapeutics Market 2015-2025 (US$ Mn)
FIG. 28 Rest of MEA Digital Therapeutics Market 2015-2025 (US$ Mn)

List of Tables

TABLE 1 Global Digital Therapeutics Market Share, by Product Type, 2016 (US$ Mn)
TABLE 2 Global Digital Therapeutics Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 3 Global Digital Therapeutics Market, by Geography, 2015 – 2025 (US$ Mn)
TABLE 4 North America Digital Therapeutics Market, by Product Type , 2015 – 2025(US$ Mn)
TABLE 5 North America Digital Therapeutics Market, by Application, 2015 – 2025(US$ Mn)
TABLE 6 North America Digital Therapeutics Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 7 Europe Digital Therapeutics Market, by Product Type, 2015 – 2025(US$ Mn)
TABLE 8 Europe Digital Therapeutics Market, by Application, 2015 – 2025(US$ Mn)
TABLE 9 Europe Digital Therapeutics Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 10 Asia Pacific Digital Therapeutics Market, by Product Type, 2015 – 2025(US$ Mn)
TABLE 11 Asia Pacific Digital Therapeutics Market, by Application, 2015 – 2025(US$ Mn)
TABLE 12 Asia Pacific Digital Therapeutics Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 13 Latin America Digital Therapeutics Market, by Product Type, 2015 – 2025(US$ Mn)
TABLE 14 Mn)
TABLE 15 Latin America Digital Therapeutics Market, by Application, 2015 – 2025(US$ Mn)
TABLE 16 Latin America Digital Therapeutics Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 17 Middle East And Africa Digital Therapeutics Market, by Product Type, 2015 – 2025(US$ Mn)
TABLE 18 (US$ Mn)
TABLE 19 Middle East And Africa Digital Therapeutics Market, by Application, 2015 – 2025(US$ Mn)
TABLE 20 Middle East And Africa Digital Therapeutics Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 21 2Morrow, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 22 Canary Health, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 23 Doximity, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 24 Evolent Health, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 25 Livongo Health: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 26 Mango Health, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 27 Nanobiosym, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 28 Noom Health, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 29 Omada Health, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 30 Pear Therapeutics, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 31 Perfint Healthcare Pvt. Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 32 Propeller Health: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 33 Proteus Digital Health: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 34 Twinehealth, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 35 WellDoc Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 36 Zest Health: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)

Frequently Asked Questions

What is the size of Digital Therapeutics Market?

The market for Digital Therapeutics Market is expected to reach US$ 8.5 Bn By 2025.

What is the Digital Therapeutics Market CAGR?

The Digital Therapeutics Market is expected to see significant CAGR growth over the coming years, at 23.2%.

What is the Forecast period considered for Digital Therapeutics Market?

The report is forecasted from 2017-2025.

What is the base year considered for Digital Therapeutics Market?

The base year of this report is 2016.

Who are the major players in this market?

Evolent Health, Inc., Perfint Healthcare Pvt. Ltd., Nanobiosym, Inc., Zest Health, Doximity, Inc., Pear Therapeutics, Inc., Evolent Health, Inc., WellDoc, Inc., 2Morrow, Inc., Proteus Digital Health, Livongo Health, Twinehealth, Inc., Propeller Health, Mango Health, Inc are some of the major players in the global market.

Glycated Albumin Assay Market

Published:
Report ID: 33574

Proliferative Diabetic Retinopathy Market

Published:
Report ID: 33536

Endoscopic Ultrasound (EUS) Needles Market

Published:
Report ID: 4131

Healthcare POS Terminals Market

Published:
Report ID: 13903

Optogenetics Market

Published:
Report ID: 8143

Medical Robotics Market

Published:
Report ID: 14075

Ablation Devices Market

Published:
Report ID: 1062

Medical Imaging Reagents Market

Published:
Report ID: 8770

X-Ray Security Screening Market

Published:
Report ID: 9312

Metal Implants and Medical Alloys Market

Published:
Report ID: 32899

Venous Thromboembolism (VTE) Treatment Market

Published:
Report ID: 11666

X-Ray Equipment Market

Published:
Report ID: 9306

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN